Sun Fights US Charges Over Delays
Indian Firm Pushes Back Against Charges Of Delaying Market Entry
Sun Pharmaceutical Industries is back before US courts as it contests US antitrust charges filed by plaintiffs over the delayed market entry of generic versions of three major drugs.
